facebook twitter linkedin
  • images/stories/slider.png
  • images/stories/slider2.png
  • images/stories/slider3.png
  • images/stories/slider4.png

NEWS RELEASES

  • Selvita exhibits at the ChemOutsourcing 2015 conference

    Krakow, 14 August 2015 - Selvita will participate and exhibit at the upcoming Pharma ChemOutsourcing 2015 conference, which will take place 14 - 17 Septeber 2015, in Long Branch, NJ.   ChemOutsourcing is the largest USA-based API show attracting an…

    Read More...

  • Selvita shows dynamic revenue growth in H1 2015

    Kraków, 13 August 2015 - The first half-year of 2015 is the third consecutive six-month period in which the Selvita Group achieved an operating profit. This positive result is the effect of the continued profitable operations in both innovations and…

    Read More...

  • Selvita initiates IND-enabling Studies for its first-in-class PIM/FLT3 inhibitor

    Krakow, 31 March 2015 - Selvita (WSE:SLV), the largest drug discovery company in Central and Eastern Europe, announced today that it is commencing IND-enabling studies for SEL24 project, the company’s first oncology drug candidate. &n SEL24 is a nov…

    Read More...